Reporter

January 20, 2022

VUMC to support $170 million NIH nutrition research initiative

By Paul Govern
January 20, 2022

Erasmus named medical director of the Vanderbilt Lung Transplant Program

David Erasmus, MBChB, MD, assistant professor of Medicine, joined Vanderbilt University Medical Center earlier this month as medical director of the Vanderbilt Lung Transplant Program.

By Matt Batcheldor
January 20, 2022

Vanderbilt mourns loss of tireless philanthropist Dugas

Laura Jo Turner Dugas, who along with her brothers Cal Jr. and Steve Turner and their families, have been longtime supporters of Vanderbilt University Medical Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt, died on Dec. 26, 2021. She was 84.

By Nancy Humphrey
January 20, 2022

Education, school quality top concerns for parents: poll

A new poll of Tennessee parents from the Vanderbilt Center for Child Health Policy has found that education and school quality top the list of parental concerns in the state.

By Jake Lowary
January 20, 2022

Omicron evades some but not all monoclonal antibodies: study

A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States.

By Bill Snyder
January 20, 2022

Pozzi elected president of Society for Matrix Biology

Vanderbilt’s Ambra Pozzi, PhD, has been elected president of the American Society for Matrix Biology (ASMB), a scientific organization that promotes research on the extracellular matrix with the aim of improving human health.

By Bill Snyder
January 19, 2022

Study identifies molecular trigger of severe injury-induced inflammatory response

Vanderbilt researchers have discovered that early inappropriate activation of the enzyme plasmin caused by severe injury is a trigger of systemic inflammatory response syndrome and resulting organ failure.
By Leigh MacMillan
January 19, 2022

Clinical score can guide PRRT therapy decisions for neuroendocrine tumors

A clinical score system developed by researchers at Vanderbilt-Ingram Cancer Center (VICC) has been validated that can guide peptide receptor radionuclide therapy treatment decisions.
By Tom Wilemon
January 18, 2022

Ensuring the “best possible” medication history

About 80% of hospital admission electronic records were missing a drug prescribed to an older adult, Vanderbilt researchers found, highlighting the need for a multipronged approach to address medication discrepancies and support safe prescribing practices.
By Bill Snyder
January 17, 2022

Inaugural members of the Vanderbilt Academy for Excellence in Clinical Medicine announced

The inaugural members of the Vanderbilt Academy for Excellence in Clinical Medicine (AECM) have been chosen.
By John Howser
January 17, 2022

H. pylori, lipid loss and stomach cancer

H. pylori infection — a strong risk factor for stomach cancer — changes the composition of stomach lipids, which could offer new biomarkers for detecting premalignant changes, Vanderbilt researchers discovered.
By Leigh MacMillan
January 14, 2022

Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy

A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors.
By Tom Wilemon
January 13, 2022

The role of integrins in kidney “integrity”

Receptors called integrins play a critical role in maintaining the structure of the kidney, Vanderbilt researchers have discovered.
By Bill Snyder
1 … 106 107 108 109 110 … 725